Pharmexa-Epimmune Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Pharmexa-Epimmune General Information

Description

Developer of cancer vaccines. The company engages in the manufacture of pharmaceuticals used in the treatment of cancer, serious chronic and infectious diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
VaxOnco
Primary Office
  • 5820 Nancy Ridge Drive
  • San Diego, CA 92121
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmexa-Epimmune Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharmexa-Epimmune‘s full profile, request access.

Request a free trial

Pharmexa-Epimmune Patents

Pharmexa-Epimmune Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2007300663-A1 Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions Abandoned 21-Jul-2006 0000000000
CA-2658559-A1 Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions Abandoned 21-Jul-2006 0000000000
EP-2069376-A2 Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions Withdrawn 21-Jul-2006 0000000000
EP-2069376-A4 Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions Withdrawn 21-Jul-2006 0000000000 0
US-20090317412-A1 Induction of an immune response against streptococcus pneumoniae polyaccharides Abandoned 04-Jun-2004 A61K39/09 0

Pharmexa-Epimmune Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pharmexa-Epimmune‘s full profile, request access.

Request a free trial